These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9279577)

  • 21. Immunoprophylactic control of bovine babesiosis: role of exoantigens of Babesia.
    Montenegro-James S
    Trans R Soc Trop Med Hyg; 1989; 83 Suppl():85-94. PubMed ID: 2696166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Live and soluble antigens for cattle protection to Babesia bigemina.
    Echaide IE; de Echaide ST; Guglielmone AA
    Vet Parasitol; 1993 Dec; 51(1-2):35-40. PubMed ID: 8128585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virulence and heterologous strain immunity of South African and Australian Babesia bovis strains with reduced pathogenicity.
    De Vos AJ; Bessenger R; Fourie CG
    Onderstepoort J Vet Res; 1982 Sep; 49(3):133-6. PubMed ID: 7177589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Field challenge of cattle vaccinated with a combined Babesia bovis and Babesia bigemina frozen immunogen.
    Alvarez JA; Ramos JA; Rojas EE; Mosqueda JJ; Vega CA; Olvera AM; Figueroa JV; Cantó GJ
    Ann N Y Acad Sci; 2004 Oct; 1026():277-83. PubMed ID: 15604506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a Babesia bovis live attenuated vaccine.
    Alonso M; Blandino T; Mendoza E; Savon L; Camacho M
    Arch Med Res; 1994; 25(2):273-7. PubMed ID: 7919825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of an attenuated live vaccine against babesiosis in native cattle in an endemic area.
    Ojeda JJ; Orozco L; Flores R; Rojas C; Figueroa JV; Alvarez JA
    Transbound Emerg Dis; 2010 Apr; 57(1-2):84-6. PubMed ID: 20537115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Babesiosis of cattle.
    Bock R; Jackson L; de Vos A; Jorgensen W
    Parasitology; 2004; 129 Suppl():S247-69. PubMed ID: 15938514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An immunisation trial with in vitro produced Babesia bigemina exoantigens.
    Beniwal RP; Nichani AK; Rakha NK; Sharma RD; Sarup S
    Trop Anim Health Prod; 1997 Nov; 29(4 Suppl):124S-126S. PubMed ID: 9512758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Babesiosis Vaccines: Lessons Learned, Challenges Ahead, and Future Glimpses.
    Rathinasamy V; Poole WA; Bastos RG; Suarez CE; Cooke BM
    Trends Parasitol; 2019 Aug; 35(8):622-635. PubMed ID: 31281025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a frozen trivalent attenuated vaccine against Babesiosis and anaplasmosis in Brazil.
    Vidotto O; Barbosa CS; Andrade GM; Machado RZ; da Rocha MA; Silva SS
    Ann N Y Acad Sci; 1998 Jun; 849():420-3. PubMed ID: 9668502
    [No Abstract]   [Full Text] [Related]  

  • 31. Advances in the development of molecular tools for the control of bovine babesiosis in Mexico.
    Mosqueda J; Figueroa JV; Alvarez A; Bautista R; Falcon A; Ramos A; Canto G; Vega CA
    Parassitologia; 2007 May; 49 Suppl 1():19-22. PubMed ID: 17691602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-thawing viability of vaccines for bovine babesiosis and anaplasmosis cryopreserved with glycerol.
    Mangold AJ; Aguirre DH; Guglielmone AA
    Vet Parasitol; 1990 Nov; 37(3-4):301-6. PubMed ID: 2267730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transgenic Babesia bovis lacking 6-Cys sexual-stage genes as the foundation for non-transmissible live vaccines against bovine babesiosis.
    Alzan HF; Cooke BM; Suarez CE
    Ticks Tick Borne Dis; 2019 Apr; 10(3):722-728. PubMed ID: 30711475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Babesia bovis: analysis of and preliminary vaccination studies with a defined infected erythrocyte membrane binding antigen.
    Goodger BV; Waltisbuhl DJ; Wright IG; White M
    Int J Parasitol; 1992 Jul; 22(4):533-5. PubMed ID: 1644530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination against canine babesiosis.
    Schetters T
    Trends Parasitol; 2005 Apr; 21(4):179-84. PubMed ID: 15780840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships between vaccine and virulent strains of Babesia bovis during co-infection in calves.
    Jorgensen WK; Jeston PJ; Bowles PM; Croft J; Lew AE; Molloy JB; Dalgliesh RJ
    Aust Vet J; 1998 Jan; 76(1):57-8. PubMed ID: 9578770
    [No Abstract]   [Full Text] [Related]  

  • 37. Emerging perspectives in the research of bovine babesiosis and anaplasmosis.
    Suarez CE; Noh S
    Vet Parasitol; 2011 Aug; 180(1-2):109-25. PubMed ID: 21684084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved disease resistance after Babesia divergens vaccination.
    Edelhofer R; Kanout A; Schuh M; Kutzer E
    Parasitol Res; 1998; 84(3):181-7. PubMed ID: 9521006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of a nonviable culture-derived Babesia bovis vaccine.
    Kuttler KL; Levy MG; James MA; Ristic M
    Am J Vet Res; 1982 Feb; 43(2):281-4. PubMed ID: 7046534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of diminazene block treatment on live redwater vaccine reactions.
    Combrink MP; Troskie PC
    Onderstepoort J Vet Res; 2004 Jun; 71(2):113-7. PubMed ID: 15373333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.